NEJM:骨石化症案例报道

2015-09-17 MedSci MedSci原创

一名8岁的男孩因右腿出现急性的疼痛发作而来院就诊。X光片检查显示其右腿股骨干存在稳定性骨折(如图A所示),且可见股骨干远端呈现锥形瓶的畸形(如图B所示)。据了解,该男孩在其出生6个月时曾被诊断患有神经母细胞瘤,但在之后的5年里通过采用环磷酰胺和每个月静脉注射双磷酸盐进行治疗后,症状一直有所缓解。此后停止双磷酸盐治疗18个月,由于担心病情变化进行常规X线成像检查检测,以防演变成骨石化症。实验室检测、

一名8岁的男孩因右腿出现急性的疼痛发作而来院就诊。


X光片检查显示其右腿股骨干存在稳定性骨折(如图A所示),且可见股骨干远端呈现锥形瓶的畸形(如图B所示)。  


据了解,该男孩在其出生6个月时曾被诊断患有神经母细胞瘤,但在之后的5年里通常采用环磷酰胺和每个月静脉注射双磷酸盐进行治疗后,症状一直有所缓解。

此后停止双磷酸盐治疗18个月,由于担心病情变化进行常规X线成像检查检测,以防演变成骨石化症。

实验室检测、X线成像以及基因检测均无发现任何遗传或其他原因获得性骨疾病,包括原发性骨髓疾病,重金属中毒,骨代谢性疾病,和其他发育不良。

从图B中可见,正常骨段与骨石化段之间的分阶段,呈梯次性生长。而这一现象与骨石化症的表现更加地符合。

目前,病人存在骨石化端与正常骨之间发生骨折的风险,主治医生建议其勿进行强烈的运动,并坚持进行年度随访。

1年半后,该男孩没有出现新的症状和骨折。

原始出处:

Andras Heczey, M.D.,Chrystal Louis, et al.Osteopetrosis and Erlenmeyer-Flask Deformity.N Engl J Med.2015

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=60786, encodeId=49b760e8679, content=不错,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60787, encodeId=fff960e87ef, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60788, encodeId=8c4360e8858, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60789, encodeId=933b60e893b, content=值得进一步关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38239, encodeId=9d733823917, content=真不错,涨姿势, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1a01625167, createdName=zhouxue1990, createdTime=Thu Oct 08 23:18:00 CST 2015, time=2015-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37678, encodeId=f8953e678ea, content=我是骨科医生,很喜欢med的骨科板块,从科普到高端都有, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75bb1617091, createdName=Bobby7868, createdTime=Sun Oct 04 01:58:00 CST 2015, time=2015-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37212, encodeId=e11c3e212b1, content=真不错,涨姿势, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75bb1617091, createdName=Bobby7868, createdTime=Thu Sep 24 01:30:00 CST 2015, time=2015-09-24, status=1, ipAttribution=)]
    2016-01-27 doctording1

    不错,赞一个

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=60786, encodeId=49b760e8679, content=不错,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60787, encodeId=fff960e87ef, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60788, encodeId=8c4360e8858, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60789, encodeId=933b60e893b, content=值得进一步关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38239, encodeId=9d733823917, content=真不错,涨姿势, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1a01625167, createdName=zhouxue1990, createdTime=Thu Oct 08 23:18:00 CST 2015, time=2015-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37678, encodeId=f8953e678ea, content=我是骨科医生,很喜欢med的骨科板块,从科普到高端都有, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75bb1617091, createdName=Bobby7868, createdTime=Sun Oct 04 01:58:00 CST 2015, time=2015-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37212, encodeId=e11c3e212b1, content=真不错,涨姿势, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75bb1617091, createdName=Bobby7868, createdTime=Thu Sep 24 01:30:00 CST 2015, time=2015-09-24, status=1, ipAttribution=)]
    2016-01-27 doctording1

    这篇文章有一定深度

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=60786, encodeId=49b760e8679, content=不错,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60787, encodeId=fff960e87ef, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60788, encodeId=8c4360e8858, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60789, encodeId=933b60e893b, content=值得进一步关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38239, encodeId=9d733823917, content=真不错,涨姿势, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1a01625167, createdName=zhouxue1990, createdTime=Thu Oct 08 23:18:00 CST 2015, time=2015-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37678, encodeId=f8953e678ea, content=我是骨科医生,很喜欢med的骨科板块,从科普到高端都有, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75bb1617091, createdName=Bobby7868, createdTime=Sun Oct 04 01:58:00 CST 2015, time=2015-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37212, encodeId=e11c3e212b1, content=真不错,涨姿势, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75bb1617091, createdName=Bobby7868, createdTime=Thu Sep 24 01:30:00 CST 2015, time=2015-09-24, status=1, ipAttribution=)]
    2016-01-27 doctording1

    是一篇不错的文章

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=60786, encodeId=49b760e8679, content=不错,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60787, encodeId=fff960e87ef, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60788, encodeId=8c4360e8858, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60789, encodeId=933b60e893b, content=值得进一步关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38239, encodeId=9d733823917, content=真不错,涨姿势, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1a01625167, createdName=zhouxue1990, createdTime=Thu Oct 08 23:18:00 CST 2015, time=2015-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37678, encodeId=f8953e678ea, content=我是骨科医生,很喜欢med的骨科板块,从科普到高端都有, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75bb1617091, createdName=Bobby7868, createdTime=Sun Oct 04 01:58:00 CST 2015, time=2015-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37212, encodeId=e11c3e212b1, content=真不错,涨姿势, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75bb1617091, createdName=Bobby7868, createdTime=Thu Sep 24 01:30:00 CST 2015, time=2015-09-24, status=1, ipAttribution=)]
    2016-01-27 doctording1

    值得进一步关注

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=60786, encodeId=49b760e8679, content=不错,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60787, encodeId=fff960e87ef, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60788, encodeId=8c4360e8858, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60789, encodeId=933b60e893b, content=值得进一步关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38239, encodeId=9d733823917, content=真不错,涨姿势, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1a01625167, createdName=zhouxue1990, createdTime=Thu Oct 08 23:18:00 CST 2015, time=2015-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37678, encodeId=f8953e678ea, content=我是骨科医生,很喜欢med的骨科板块,从科普到高端都有, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75bb1617091, createdName=Bobby7868, createdTime=Sun Oct 04 01:58:00 CST 2015, time=2015-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37212, encodeId=e11c3e212b1, content=真不错,涨姿势, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75bb1617091, createdName=Bobby7868, createdTime=Thu Sep 24 01:30:00 CST 2015, time=2015-09-24, status=1, ipAttribution=)]
    2015-10-08 zhouxue1990

    真不错,涨姿势

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=60786, encodeId=49b760e8679, content=不错,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60787, encodeId=fff960e87ef, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60788, encodeId=8c4360e8858, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60789, encodeId=933b60e893b, content=值得进一步关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38239, encodeId=9d733823917, content=真不错,涨姿势, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1a01625167, createdName=zhouxue1990, createdTime=Thu Oct 08 23:18:00 CST 2015, time=2015-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37678, encodeId=f8953e678ea, content=我是骨科医生,很喜欢med的骨科板块,从科普到高端都有, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75bb1617091, createdName=Bobby7868, createdTime=Sun Oct 04 01:58:00 CST 2015, time=2015-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37212, encodeId=e11c3e212b1, content=真不错,涨姿势, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75bb1617091, createdName=Bobby7868, createdTime=Thu Sep 24 01:30:00 CST 2015, time=2015-09-24, status=1, ipAttribution=)]
    2015-10-04 Bobby7868

    我是骨科医生,很喜欢med的骨科板块,从科普到高端都有

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=60786, encodeId=49b760e8679, content=不错,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60787, encodeId=fff960e87ef, content=这篇文章有一定深度, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60788, encodeId=8c4360e8858, content=是一篇不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60789, encodeId=933b60e893b, content=值得进一步关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Wed Jan 27 12:54:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38239, encodeId=9d733823917, content=真不错,涨姿势, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1a01625167, createdName=zhouxue1990, createdTime=Thu Oct 08 23:18:00 CST 2015, time=2015-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37678, encodeId=f8953e678ea, content=我是骨科医生,很喜欢med的骨科板块,从科普到高端都有, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75bb1617091, createdName=Bobby7868, createdTime=Sun Oct 04 01:58:00 CST 2015, time=2015-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=37212, encodeId=e11c3e212b1, content=真不错,涨姿势, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75bb1617091, createdName=Bobby7868, createdTime=Thu Sep 24 01:30:00 CST 2015, time=2015-09-24, status=1, ipAttribution=)]
    2015-09-24 Bobby7868

    真不错,涨姿势

    0

相关资讯

Nature:骨头生长与血管形成有关

有证据表明,血管 (尤其是它们的内皮细胞) 控制器官的生长、平衡和再生。在本期Nature上发表的两篇论文中,Ralf Adams及同事证明,骨头血管含有专门支持骨成熟和再生的内皮细胞。 Anjali Kusumbe等人在小鼠骨骼系统内识别出一个在介导骨生长中起关键作用的毛细血管亚型。这些血管含有所谓的 “H-型内皮细胞”,它们优先与骨祖细胞关联,在衰老过程中数量减少。Hypoxia-induc

Injury:三束缝合法治疗急性跟腱断裂手术技术

急性跟腱断裂最佳治疗方案在临床上存在较多争议。有研究发现,急性跟腱锻炼通过保守石膏制动固定或者手术修复等均可以取得愈合,并且功能基本类似;两者的差别在于,前者有更高的再断裂率,后者有更高的并发症发生率。 中国的临床医生通常主张对跟腱断裂采取更为激进的手术治疗,手术缝合断端跟腱时较为常用的是Krakow锁边缝合法(Krakow locking loop technique,图1);Jaakkola

JNCI:MAF可能是乳腺癌骨转移关键基因

骨转移是可以通过药物唯一控制的转移类型,但不能被治愈。仅给给予一次的转移已被确定,这通常是太迟了。初步研究确定了用于治疗转移同样也可用于防止它的药物,并确定那些处于发展骨转移的风险的患者,因此非常重要。“这是在IRB巴塞罗那取得的发现,可能对医生很有用处,并能避免没有风险的患者不必要的治疗,”Gomis建议。每年大约有一百万例新的乳腺癌病例被诊断。预防性治疗骨转移癌具有不必要的副作用,并且成本高,

PNAS:长期锻炼身体的好处在哪里

骨质量、尺寸和强度因为青年时期的身体活动而增加,但是尚不清楚这些身体活动的收益是否会在整个成年期持续存在。 为了研究这个问题,Stuart J. Warden及其同事比较了103名现役和退役的专业棒球运动员的投球臂和非投球臂的肱骨质量、尺寸和强度。 这组作者报告说,现役的棒球运动员的投球臂比非投球臂表现出了更大的肱骨质量、尺寸和强度,投球臂的骨强度至多是非投球臂的两倍。在退役后,停止投球的运动

刘勇&裴国:献严重创伤保肢与截肢的标准指征研究进展

严重的肢体创伤常同时累及皮肤、肌肉、骨骼、神经、血管等重要结构,一直是创伤骨科治疗中一个非常棘手的问题,保肢与截肢的手术指征也存在争论,现结合有关文献作一综述。 严重创伤时保肢还是截肢往往取决于手术医生的临床经验和对伤情的判断。常可能发生2种错误判断:一是对伤情评估不足,应该截肢者未早期截肢,致使延期截肢,增加了感染机会,延长了住院时间,甚至导致患者死亡;二是对伤情估计过重,不该截肢者反而截

世界杯(医学篇)

世界杯如火如荼的来了,各国足球明星们正在绿茵草上挥洒汗水,也有不少在激烈的运动中受伤,以下列出常见的几种运动损伤。 一、关节韧带损伤 关节韧带损伤是由间接外力作用引起的一种闭合性损伤,损伤的部位通常在踝、膝关节等,例如,外脚背踢球和盘带球时,踝关节经常做内翻动作,易损伤踝关节外侧距腓前韧带,这是最常见的踝关节损伤类型;脚内侧推球、前脚掌踢球及双方运动员发生脚碰撞的情况下,易导致